Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling

Pancreatic ductal adenocarcinoma (PDAC) is the most malignant tumor. Zinc finger and SCAN domain-containing protein 23 (ZSCAN23) is a new member of the SCAN domain family. The expression regulation and biological function remain to be elucidated. In this study, we explored the epigenetic regulation and the function of ZSCAN23 in PDAC. ZSCAN23 was methylated in 60.21% (171/284) of PDAC and its expression was regulated by promoter region methylation. The expression of ZSCAN23 inhibited cell proliferation, colony formation, migration, invasion, and induced apoptosis and G1/S phase arrest. ZSCAN23 suppressed Panc10.05 cell xenograft growth in mice. Mechanistically, ZSCAN23 inhibited Wnt signaling by interacting with myosin heavy chain 9 (MYH9) in pancreatic cancer cells. ZSCAN23 is frequently methylated in PDAC and may serve as a detective marker. ZSCAN23 suppresses PDAC cell growth both in vitro and in vivo.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:25

Enthalten in:

Cancer biology & therapy - 25(2024), 1 vom: 31. März, Seite 2302924

Sprache:

Englisch

Beteiligte Personen:

Du, Qian [VerfasserIn]
Zhang, Meiying [VerfasserIn]
Gao, Aiai [VerfasserIn]
He, Tao [VerfasserIn]
Guo, Mingzhou [VerfasserIn]

Links:

Volltext

Themen:

DNA methylation
Journal Article
Pancreatic ductal adenocarcinoma
Research Support, Non-U.S. Gov't
Tumor suppressor
Wnt signaling pathway
ZSCAN23

Anmerkungen:

Date Completed 06.02.2024

Date Revised 11.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15384047.2024.2302924

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36717393X